Mallinckrodt Stock Price, News & Analysis

MNKTQ OTC

Company Description

Mallinckrodt (OTC: MNKTQ) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.

MNKTQ stock has declined 98.5% over the past year.

This page provides a comprehensive overview of MNKTQ stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-98.46%

Performance 1 year

$0.0

Market Cap

13.4M

Shares outstanding

Mallinckrodt (MNKTQ) stock. Over the past 12 months, the stock has lost 98.5%.

Latest News

View All

February 2, 2024

—

Mallinckrodt Announces Board of Directors and Leadership Updates

management

January 22, 2024

—

Mallinckrodt Presents New Data on TERLIVAZ® (terlipressin) for Injection at the Society of Critical Care Medicine (SCCM) 2024 Critical Care Congress

November 14, 2023

-100.00%

Mallinckrodt Completes Financial Restructuring and Irish Examinership Proceedings and Emerges From Chapter 11

November 8, 2023

+9.00%

Mallinckrodt to Present Breadth of Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American Association for the Study of Liver Diseases (AASLD) 2023 Liver Meeting

conferences

November 7, 2023

+12.50%

Mallinckrodt plc (in Examinership) Reports Third Quarter 2023 Financial Results

earnings

November 1, 2023

-8.54%

Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American Society of Nephrology (ASN) Kidney Week 2023 Scientific Meeting

conferences

Mallinckrodt has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 4 with negative movement. Key topics include management, conferences, earnings. View all MNKTQ news →

SEC Filings

View All

No SEC filings available for MNKTQ.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

MNKTQ Company Profile & Sector Positioning

Mallinckrodt (MNKTQ) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.